Navigation Links
CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Date:5/15/2008

that represent global analysis of current sponsor and CRO practices. The 2008 edition features more than 90 completely new charts analyzing the clinical research industry along with updates for hundreds of charts and tables that have become a requirement for industry executives, market researchers, and analysts.

To purchase your copy of State of the Clinical Trials Industry 2008 at the introductory rate of $549 (+ s/h), regular $699 (Special offer of $549 through May 30). Call us at 800-765-9647 or visit our online bookstore at http://www.centerwatch.com.

Corporate licenses are available. For more information, contact us at sales@centerwatch.com or 866-219-3440, ext. 4.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for professionals and patients. A Boston-based publishing and information services company focusing on the clinical research industry, CenterWatch is a business of Jobson Medical Information, LLC. CenterWatch provides proprietary data and information about clinical trials through a variety of publications, databases and information services used by pharmaceutical and biotech companies, CROs, SMOs and investigative sites involved in all aspects of clinical trials.

As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish information about active clinical trials that could be accessed by patients and their advocates. Today, CenterWatch has one of the largest databases of clinical trials actively recruiting patients on the Internet. For more information about CenterWatch's publications and services, please visit http://www.centerwatch.com.


'/>"/>
SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
2. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
3. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
4. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
6. Immunosyn Corporation Releases SF-1019 Study Results
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 An...infectious diseases in the developing world has pr...ademic researchers, non-profit product development...chnology companies. As noted today in a symposium ... of Tropical Medicine and Hygiene (ASTMH), these c...
(Date:11/20/2009)... , , BOSTON, Nov. 20 Th...rcuit upheld an earlier District Court ruling yest...Average Wholesale Price (AWP) pharmaceutical litig...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...ettlement that awarded consumers who purchased the...
(Date:11/20/2009)... , , CARY, N.C., Nov. 20 /PRNewswire-Firs...CRTX ), a specialty pharmaceutical company focused...ificant products primarily for the respiratory and...ved a Warning Letter from the Food and Drug Admini...wable tablets (Phenylephrine HCl 10 mg, Pyrilamine...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Weight Loss Surgery Simplified 47681 1Weight Loss Surgery Simplified 47681 2Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 1Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 2Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 1Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 2
...ell engaging antibody (BiTE) showing clinical bene...nts own T cells to recognize and attack ...ug. 14 Micromet, Inc.,(Nasdaq: MITI ), a biophar...ntibodies for the treatment of cancer, inflammatio...tion of a Phase 1 clinical study(1) on its,BiTE(R)...
...Aug. 13 As biotechnology,pharmaceutical and medic...als beyond their own borders to other parts of the...ica, complicated regulatory environments,challenge... an analysis by,Aon Corporation (NYSE: AOC ). Aon...mpanies a visual representation of the complex ins...
Other Medicine Technology:Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4
(Date:11/23/2009)...,, KANSASCITY,Mo.,Nov.23/PRNewswire/--Christ...largestprivatelyownedinsurancebrokerage.Hoehnewill...BenefitServices practiceinLockton,s Minneapolis of...prnh/20090415/CG99351LOGO ) ,, "Wearethrilledto...fLocktonInternationalBenefitServices."Shebroadenso...
(Date:11/23/2009)..., Since 1996, crop plants genetically modified to...ain insects, yet safe for people, have been plante... popularity of these Bt crops, named after the bac...ability to kill some major pests, allowing farmers... reducing insecticide sprays. , However, since i...
(Date:11/23/2009)... Study found one more than doubled chances, while ..., Nov. 23 (HealthDay News) -- Children whose mothe...lead have more than double the risk of having atte...er children, new research shows. , And with exp...having ADHD soared. Children whose mothers smoked ...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompan...erservicesforthehealthcareindustry,hasearnedrecogn...odernHealthcare ,theindustry,sleadingtrademagazine...ngfirmsbasedonBeryl,s2008businessresults,whichenab..., Berylattributesthisgrowthtoitsinnovativeproduc...
(Date:11/23/2009)..., Information about Oxyco...y launched DopeStats.com. The new site is a statis...d use rates of Oxycodone in each county in the Uni...le who have used the drug for recreational or medi... FL (PRWEB) November 23, 2009 -- Legal and illegal...
Breaking Medicine News(10 mins):Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2
...an biotech major Biocon Ltd has roped in Bayer Hea...sugen in the Chinese market, the company //said in...biotech firm plans to launch Insugen in China by 2... countries in the Asia-Pacific region later. The i...
...sh Sindhi, a surgeon and a researcher at the child...how the new low dose anti rejection protocol //has...al transplant recipients. Research performed b...s drug doses and eliminates steroids altogether in...
...Baldomero Olivera said that the ruthless fish-eati...c back pain.// He is planning to present his f...one snails, with their striking patterns and elega...aturday and Sunday, October 7-8, 10 a.m.-5 p.m. at...
...rding to the study conducted by the Queen's Univer... how genes work to protect the aortic muscle new t...ts suffering from arteriosclerosis. It is one ...-1 (HO-1) markedly protects the arteriosclerois-pr...
...rding to the scientist from the Victorian Breast C...east stem cells which have undergone some mutation...ancers.// The Walter and Eliza Hall Institute ...esterone. This characteristic is very similar to t...
...rding to a new research conducted at the Universit...nd that increased serotonin aids to curb appetite.... stimulated by various drugs such Fen-phen and oth...ffects. The study, which tested the effect of seve...
Other Medicine News:Health News:Bayer to Market Biocon Insulin in China 2Health News:Low Dose Anti Rejection Protocol Helps Intestinal Transplant Recipients 2Health News:Genes Identified To Protect Heart Muscles 2Health News:Mutation in Breast Stem Cells Lead to Breast Cancer 2Health News:Serotonin the Answer for Anti-Obesity Treatment 2
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: